Bio-Shield 2019-nCoV IgG (C1148/C1196)

Principle: An indirect ELISA method
Automation: Yes
Approvals: Currently Under approval by FDA, Pending CE IVD mark
Suitability: For Medical Professionals and Scientists
Capital equipment required: Yes - A typical ELISA photometer
Description:
Key Points:
Bio-Shield 2019-nCoV IgG, is a semi-quantitative ELISA test for the determination of IgG antibodies against SARS-CoV-2 in human serum or plasma (Heparin, EDTA or Citrate) specimens
Key Points:
- Semi-quantitative ELISA test with single-break strip plate with 48 wells (6 strips) or 96 wells (12 strips)
- High Sensitivity (97.43% ) and Specificity (99.85%)
- Test time: 90 min
- Compatible with automated ELISA systems
- Shelf Life: 12 months | Storage 2-8 °C
Please note : Any products described on this page are
for Research Use Only and not intended for clinical diagnostic procedures unless otherwise stated.
Areas:
Tags:
Company contact details:
ProGnosis Biotech S.A view full details
Greece
Website: Visit Website
Tel: + 30-2410623922
ProGnosis Biotech S.A view full details
Greece
Website: Visit Website
Tel: + 30-2410623922